600420.SS

Shanghai Shyndec Pharmaceutical Co., Ltd. [600420.SS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

600420.SS Stock Summary

In the News

600420.SS Financial details

Company Rating
Buy
Market Cap
12.18B
Income
860.38M
Revenue
12.4B
Book val./share
9.23
Cash/share
4.17
Dividend
0.1
Dividend %
1.06%
Employees
11.49K
Optionable
No
Shortable
Yes
Earnings
29 Apr 2022
P/E
12.99
Forward P/E
-
PEG
-
P/S
1.02
P/B
0.91
P/C
2.18
P/FCF
9.41
Quick Ratio
2.31
Current Ratio
3.04
Debt / Equity
0.09
LT Debt / Equity
0.08
-
-
EPS (TTM)
0.7
EPS next Y
-
EPS next Q
-
EPS this Y
7.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
2.9%
Revenue last 5Y
2.74%
Revenue Q/Q
-10.24%
EPS Q/Q
23.08%
-
-
-
-
SMA20
1.01%
SMA50
-11.47%
SMA100
-11.21%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
8%
ROC
0.07%
Gross Margin
37%
Oper. Margin
9%
Profit Margin
7%
Payout
37%
Shs Outstand
1.34B
Shs Float
695.64M
-
-
-
-
Target Price
-
52W Range
7.61-14.3
52W High
-34.93%
52W Low
+30.14%
RSI
53.17
Rel Volume
0.77
Avg Volume
10.06M
Volume
7.78M
Perf Week
1.22%
Perf Month
-2.25%
Perf Quarter
-
Perf Half Y
-8.07%
-
-
-
-
Beta
0.207
-
-
Volatility
0.07%, 0.31%
Prev Close
0.33%
Price
9.11
Change
0.11%

600420.SS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
10.3710.5910.6511.8411.21
Net income per share
0.650.810.760.70.75
Operating cash flow per share
1.531.11.321.432.47
Free cash flow per share
1.160.7510.982.2
Cash per share
3.44.373.053.565.26
Book value per share
6.236.596.897.38.91
Tangible book value per share
6.777.127.538.099.74
Share holders equity per share
6.236.596.897.38.91
Interest debt per share
3.613.92.773.133.04
Market cap
9.45B10.29B11.22B12.21B10.52B
Enterprise value
9.35B9.43B10.64B11.51B7.78B
P/E ratio
13.3911.0912.4614.8712.13
Price to sales ratio
0.830.840.890.880.81
POCF ratio
5.668.117.197.273.68
PFCF ratio
7.4411.889.4910.554.13
P/B Ratio
1.391.361.381.421.02
PTB ratio
1.391.361.381.421.02
EV to sales
0.830.770.850.830.6
Enterprise value over EBITDA
44.575.395.573.96
EV to operating cash flow
5.67.426.826.852.72
EV to free cash flow
7.3610.8899.933.05
Earnings yield
0.070.090.080.070.08
Free cash flow yield
0.130.080.110.090.24
Debt to equity
0.550.570.390.420.33
Debt to assets
0.230.240.170.190.17
Net debt to EBITDA
-0.04-0.42-0.29-0.34-1.4
Current ratio
1.291.491.641.592.78
Interest coverage
5.845.448.2911.299
Income quality
1.561.371.732.053.29
Dividend Yield
0.050.030.020.020.02
Payout ratio
0.650.350.230.260.21
Sales general and administrative to revenue
0.010.010.010.010.01
Research and developement to revenue
0.030.030.040.040.04
Intangibles to total assets
0.060.060.050.040.05
Capex to operating cash flow
-0.24-0.32-0.24-0.31-0.11
Capex to revenue
-0.04-0.03-0.03-0.04-0.02
Capex to depreciation
-0.55-0.56-0.52-0.64-0.36
Stock based compensation to revenue
0-0.01000
Graham number
9.5210.9310.8810.712.26
ROIC
0.10.070.080.090.06
Return on tangible assets
0.050.060.050.050.05
Graham Net
-1.47-0.64-0.87-0.421.81
Working capital
1.9B3.18B3.97B4.04B7.49B
Tangible asset value
7.39B8.19B8.88B9.53B11.26B
Net current asset value
449.61M1.24B1.73B2.19B4.21B
Invested capital
0.550.570.390.420.33
Average receivables
2.2B2.03B2.45B3.1B3.16B
Average payables
1.67B1.75B1.85B1.97B1.57B
Average inventory
2.12B2.32B2.8B3.18B2.76B
Days sales outstanding
66.2460.1484.0686.3985.18
Days payables outstanding
127.9887.71122.3979.6164.66
Days of inventory on hand
145.73137.85180.22142.89110.97
Receivables turnover
5.516.074.344.234.28
Payables turnover
2.854.162.984.585.64
Inventory turnover
2.52.652.032.553.29
ROE
0.10.120.110.10.08
Capex per share
-0.37-0.35-0.32-0.44-0.27

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.962.82.622.442.05
Net income per share
0.240.170.210.130.16
Operating cash flow per share
0.240.170.210.520.4
Free cash flow per share
0.180.120.110.480.35
Cash per share
3.835.264.084.614.17
Book value per share
7.918.918.059.719.23
Tangible book value per share
8.749.748.8510.529.96
Share holders equity per share
7.918.918.059.719.23
Interest debt per share
3.282.962.040.930.86
Market cap
9.66B10.52B14.25B14B13.71B
Enterprise value
8.94B7.78B11.51B9.34B9.23B
P/E ratio
8.8113.0612.9921.1215.66
Price to sales ratio
2.93.254.174.625.05
POCF ratio
35.2252.2451.9621.825.64
PFCF ratio
48.277.7499.7823.3529.8
P/B Ratio
1.081.021.361.161.12
PTB ratio
1.081.021.361.161.12
EV to sales
2.682.43.373.083.4
Enterprise value over EBITDA
25.7730.931.2128.0928.09
EV to operating cash flow
32.6238.6241.9614.5417.25
EV to free cash flow
44.6457.4680.5915.5720.06
Earnings yield
0.030.020.020.010.02
Free cash flow yield
0.020.010.010.040.03
Debt to equity
0.410.330.250.090.09
Debt to assets
0.20.170.140.060.06
Net debt to EBITDA
-2.05-10.9-7.43-14.03-13.65
Current ratio
2.312.782.993.043.04
Interest coverage
11.8310.7418.2614.0629.9
Income quality
1113.872.44
Dividend Yield
0.020.01000.01
Payout ratio
0.690.330.2200.88
Sales general and administrative to revenue
0.14-0.150.05-0.040.18
Research and developement to revenue
0.040.050.030.040.05
Intangibles to total assets
0.050.050.050.050.05
Capex to operating cash flow
-0.27-0.33-0.48-0.07-0.14
Capex to revenue
-0.02-0.02-0.04-0.01-0.03
Capex to depreciation
-0.35-0.31-0.67-0.220
Stock based compensation to revenue
00000
Graham number
6.585.916.185.45.85
ROIC
0.020.020.020.020.02
Return on tangible assets
0.020.010.020.010.01
Graham Net
0.321.811.83.292.89
Working capital
6.01B7.49B7.33B7.46B7.2B
Tangible asset value
9.84B11.26B11.52B13.04B13.23B
Net current asset value
2.8B4.21B4.47B6.13B5.87B
Invested capital
0.410.330.250.090.09
Average receivables
3.4B3.14B3.06B3.01B2.77B
Average payables
1.8B1.54B1.45B1.43B1.41B
Average inventory
2.93B2.62B2.45B2.39B2.34B
Days sales outstanding
87.9584.0181.4787.0386.75
Days payables outstanding
72.6758.9765.2366.1476.93
Days of inventory on hand
122.3101.21109.31109.83127.84
Receivables turnover
1.021.071.11.031.04
Payables turnover
1.241.531.381.361.17
Inventory turnover
0.740.890.820.820.7
ROE
0.030.020.030.010.02
Capex per share
-0.07-0.06-0.1-0.03-0.06

600420.SS Frequently Asked Questions

What is Shanghai Shyndec Pharmaceutical Co., Ltd. stock symbol ?

Shanghai Shyndec Pharmaceutical Co., Ltd. is a CN stock and trading under the symbol 600420.SS

What is Shanghai Shyndec Pharmaceutical Co., Ltd. stock quote today ?

Shanghai Shyndec Pharmaceutical Co., Ltd. stock price is $9.11 today.

Is Shanghai Shyndec Pharmaceutical Co., Ltd. stock public?

Yes, Shanghai Shyndec Pharmaceutical Co., Ltd. is a publicly traded company.

Something similar